MENU
+Compare
MRUS
Stock ticker: NASDAQ
AS OF
Nov 13 closing price
Price
$96.08
Change
+$0.04 (+0.04%)
Capitalization
7.29B

MRUS Merus NV Forecast, Technical & Fundamental Analysis

Merus NV is a clinical-stage immuno-oncology company... Show more

Industry: #Biotechnology
MRUS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for MRUS with price predictions
Nov 12, 2025

Momentum Indicator for MRUS turns positive, indicating new upward trend

MRUS saw its Momentum Indicator move above the 0 level on November 03, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 91 similar instances where the indicator turned positive. In of the 91 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MRUS advanced for three days, in of 263 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 243 cases where MRUS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Moving Average Convergence Divergence Histogram (MACD) for MRUS turned negative on October 16, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at .

MRUS broke above its upper Bollinger Band on November 12, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MRUS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.407) is normal, around the industry mean (24.439). P/E Ratio (0.000) is within average values for comparable stocks, (63.753). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.001). Dividend Yield (0.000) settles around the average of (0.046) among similar stocks. P/S Ratio (120.482) is also within normal values, averaging (322.723).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
MRUS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

MRUS is expected to report earnings to fall 7.14% to -116 cents per share on March 04

Merus NV MRUS Stock Earnings Reports
Q4'25
Est.
$-1.17
Q3'25
Beat
by $0.12
Q2'25
Missed
by $1.07
Q1'25
Missed
by $0.29
Q4'24
Beat
by $0.48
The last earnings report on November 12 showed earnings per share of -125 cents, beating the estimate of -137 cents. With 759.37K shares outstanding, the current market capitalization sits at 7.29B.
A.I. Advisor
published General Information

General Information

a developer of therapeutics for cancer treatment

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
Uppsalalaan 17
Phone
+31 302538800
Employees
229
Web
https://www.merus.nl
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VYMQX19.770.02
+0.10%
Voya MI Dynamic SMID Cap A
JGYIX13.59-0.12
-0.88%
JHancock Global Shareholder Yield I
ALGRX111.00-1.02
-0.91%
Alger Focus Equity I
FFPNX74.05-1.24
-1.65%
American Funds New Perspective 529-F-2
VVSGX17.11-0.55
-3.11%
VALIC Company I Small Cap Growth

MRUS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MRUS has been loosely correlated with ENTA. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if MRUS jumps, then ENTA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRUS
1D Price
Change %
MRUS100%
+0.59%
ENTA - MRUS
50%
Loosely correlated
-0.91%
NUVL - MRUS
47%
Loosely correlated
+0.91%
RVMD - MRUS
47%
Loosely correlated
+2.73%
CGON - MRUS
46%
Loosely correlated
+1.47%
IDYA - MRUS
41%
Loosely correlated
-0.19%
More